Old Web
English
Sign In
Acemap
>
authorDetail
>
Mark Korthals
Mark Korthals
University of Düsseldorf
Immunology
Minimal residual disease
Bone marrow
Transplantation
Multiple myeloma
7
Papers
176
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Author response for "Plasma membrane Ca 2+ ATPase 1 (PMCA1) but not PMCA4 is critical for B cell development and Ca 2+ homeostasis in mice"
2020
European Journal of Immunology
Mark Korthals
Laura Tech
Kristina Langnaese
Anna Gottfried
Johannes Hradsky
Ulrich Thomas
Ana Claudia Zenclussen
Monika C. Brunner-Weinzierl
Kerry Tedford
Klaus-Dieter Fischer
Show All
Source
Cite
Save
Citations (0)
Monocyte derived dendritic cells generated by IFN-α acquire mature dendritic and natural killer cell properties as shown by gene expression analysis
2007
Journal of Translational Medicine
Mark Korthals
Nancy Safaian
Ralf Kronenwett
Dagmar Maihöfer
Matthias Schott
Claudia Papewalis
Elena Diaz-Blanco
Meike Winter
Akos Czibere
Rainer Haas
Guido Kobbe
Roland Fenk
Show All
Source
Cite
Save
Citations (68)
Levels of minimal residual disease detected by quantitative molecular monitoring herald relapse in patients with multiple myeloma
2004
Haematologica
Roland Fenk
Muharrem Ak
Guido Kobbe
Ulrich Steidl
Carolin Arnold
Mark Korthals
A. Hünerlitürkoglu
Ulrich Peter Rohr
Slawomir Kliszewski
Alf Bernhardt
Rainer Haas
Ralf Kronenwett
Show All
Source
Cite
Save
Citations (36)
Pre-Transplantation Level of Minimal Residual Disease Detected by Quantitative Real-Time IgH-PCR Is a Prognostic Parameter in Patients with Multiple Myeloma.
2004
Blood
Roland Fenk
Mark Korthals
Guido Kobbe
Ulrich Steidl
Thorsten Graef
Ulrich Peter Rohr
Leilani Ruf
Barbara Hoyer
Frank Neumann
Rainer Haas
Ralf Kronenwett
Show All
Source
Cite
Save
Citations (0)
1